IMARC Group’s latest research report, titled “Active Pharmaceutical Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the market. The active pharmaceutical ingredients (API) market outlook report also includes competitor and regional analysis, and contemporary advancements in the market. The global active pharmaceutical ingredients (API) market size reached US$ 222.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 303.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.6% during 2023-2028.
Active Pharmaceutical Ingredients (API) Market Overview:
Active pharmaceutical ingredients (APIs) are the primary chemical compounds responsible for the therapeutic effects of a drug. They are commonly manufactured using various processes, including fermentation, isolation, chemical synthesis, recombinant DNA, and recovery from natural sources. They can be administered in various forms, such as tablets, capsules, injections, and topical preparations. API in a drug is precisely used for curing, diagnosis, mitigation, or prevention of human health issues. Additionally, they have a direct effect on restoring, correcting, or modifying physiological functions of the body. As a result, they have wide applications in the pharmaceuticals industry pertaining to oncology, central nervous system disorders, diabetes, neurological disorders, cardiovascular, and respiratory disorders.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/active-pharmaceutical-ingredients-market/requestsample
Global Active Pharmaceutical Ingredients (API) Market Demand Analysis:
The increasing incidences of chronic and lifestyle disorders among the masses are driving the global market. Moreover, the rising demand for generic drugs is catalyzing the market as these drugs are less expensive than branded drugs and contain the same APIs as the branded drugs. Besides, several leading players are heavily investing in extensive research and development (RD) activities to launch better-quality, low-cost APIs that can assist in the treatment of medical conditions that are beyond the scope of small molecule drugs, which is creating a positive market outlook. Other factors, such as the growing geriatric population, rising demand for over-the-counter (OTC) medications, increasing healthcare expenditure, and the rising demand for APIs for biologicals, are also influencing the market.
Top Active Pharmaceutical Ingredients Companies Worldwide:
- Pfizer Inc.
- Novartis International AG
- Sanofi SA
- Boehringer Ingelheim Group
- Bristol-Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly and Company
- GlaxoSmithKline plc
- Merck Co. Inc.
- AbbVie Inc.
Do you know more information, Contact to our analyst at– https://www.imarcgroup.com/active-pharmaceutical-ingredients-market
Key Market Segmentation:
Breakup by Drug Type:
- Innovative Active Pharmaceutical Ingredients (API)
- Generic Active Pharmaceutical Ingredients (API)
Breakup by Manufacturer:
- Captive Manufacturers
- Merchant API Manufacturers
- Innovative Merchant API Manufacturers
- Generic Merchant API Manufacturers
Breakup by Synthesis:
- Synthetic Active Pharmaceutical Ingredients (API)
- Market Breakup by Type
- Generic Synthetic APIs
- Innovative Synthetic APIs
- Biotech Active Pharmaceutical Ingredients (API)
- Market Breakup by Type
- Biosimilars
- Innovative Biotech APIs
- Market Breakup By ProductMonoclonal Antibodies
- Blood Factors
- Therapeutic Enzymes
- Fusion Proteins
- Cytokines
- Vaccines
- Market Breakup By Expression System
- Mammalian Expression Systems
- Microbial Expression Systems
- Yeast Expression Systems
- Transgenic Animal Systems
- Others
Breakup by Therapeutic Application:
- Oncology
- Cardiovascular and Respiratory
- Diabetes
- Central Nervous System Disorders
- Neurological Disorders
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800